AmCham Indonesia began March with a virtual discussion on the Gotong Royong (mutual assistance) COVID-19 vaccination program and its pending regulations, led by the Chairman of the Indonesian Chamber of Commerce and Industry (Kadin) Rosan Roeslani, and Kadin Vice-Chair Shinta Kamdani. It was moderated by AmCham Managing Director A Lin Neumann.
AmCham Vice-Chair Mira Arifin opened the meeting before the speakers were formally introduced. Rosan immediately cut to the facts and shared how the Gotong Royong program was created because of a discussion he had with President Joko Widodo in January this year.
Rosan also gave updates on the program, the most notable being the type of vaccines to be used in compliance with a new government regulation that it must not use the same brand of vaccines the government is using for its vaccination program. He also said that the vaccination rollout date had been pushed back to the beginning of April, due to waiting on the Food and Drug Monitoring Agency (BPOM).
Shinta also helped clarify several regulatory questions and said the information Kadin receives through its registration of companies interested in the program will be integrated with government systems.
Rosan also confirmed that as of now expats will not be allowed to receive vaccinations under the Gotong Royong program. He said he hoped this would change as vaccines become more widely available. He said he expected it would take more than a year for the bulk of Indonesians to be immunized and for some form of herd immunity to be achieved. The meeting concluded with a question and answer session that featured queries on vaccine procurement, distribution, and other logistical issues. AmCham supports the Gotong Royong program but hopes the expatriate community will soon be eligible for Indonesia’s vaccination programs.